JeffreyS.WeinbergMD

Associate Professor of Neurological Surgery, University Tex Houston

Dr. Weinberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I am a Professor of Neurosurgery, Deputy Chair and Vice-Chair of Clinical Operations in The Department of Neurosurgery at The University of Texas MD Anderson Cancer Center in Houston, TX. I am also the Director of the Intraoperative MRI Program and a leader in the field of the Neurosurgical Oncology with particular knowledge about intraoperative MRI and technical expertise in surgical management of primary and metastatic brain tumors, spinal cord tumors and stereotactic radiosurgery.

PubMed

46 citations
Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy
Mariko Sato, Jillian R. Gunther, Anita Mahajan, Eunji Jo, Arnold C. Paulino
Cancer. 2017-07-01
39 citations
Fusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis
Xiang Y. Han, Jeffrey S. Weinberg, Sujit S. Prabhu, Samuel J. Hassenbusch, Gregory N. Fuller
Journal of Neurosurgery. 2003-10-01
420 citations
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.
Frederick F. Lang, Charles A. Conrad, Candelaria Gomez-Manzano, W. K. Alfred Yung, Raymond Sawaya
Journal of Clinical Oncology. 2018-02-12

Plus Therapeutics to Present at 13th Annual LD Micro Main Event ConferenceDecember 1st, 2020
GT Medical Technologies Announces Data Demonstrating Positive Local Control and Safety Outcomes with GammaTile Therapy for Large Brain MetastasesAugust 18th, 2020
Glioma Survivor Thrives After Treatment at MD AndersonSeptember 12th, 2023

Clinical Development of Rhenium Nanoliposomes (RNL 186) for GlioblastomaNIH/NCI2020–2024
A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) versus Surgically Targeted Radiation Therapy (STaRT) with Gamma Tile for,GT Medical Technologies2021–2022
Decoding the Niche Specific Imaging Genomic Landscape and Heterogeneity of GlioblastomaCABI/GE In-Kind Research Grant2016–2021
Radiomic Sequencing of Glioblastoma: Decoding the Imaging Genomic Landscape and HeterogeneityRadiological Society of North America (RSNA)2015–2017